Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Babylon Holdings Limited stock logo
BBLN
Babylon
$0.55
$0.60
$0.46
$28.50
$14.10M2.42415,159 shsN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
$0.00
$0.00
$0.00
$0.03
$5K0.9517,023 shs100 shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$3.58
-3.8%
$3.72
$2.83
$6.30
$138.21M-0.0284,157 shs103,087 shs
UpHealth, Inc. stock logo
UPH
UpHealth
$0.73
$0.25
$3.19
$5.33M0.51121,201 shs348,700 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Babylon Holdings Limited stock logo
BBLN
Babylon
0.00%0.00%0.00%0.00%0.00%
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00%0.00%0.00%-75.00%-98.51%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
0.00%+0.27%-1.06%-5.34%+33.81%
UpHealth, Inc. stock logo
UPH
UpHealth
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Babylon Holdings Limited stock logo
BBLN
Babylon
N/AN/AN/AN/AN/AN/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/AN/AN/AN/AN/AN/AN/AN/A
UpHealth, Inc. stock logo
UPH
UpHealth
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Babylon Holdings Limited stock logo
BBLN
Babylon
0.00
N/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00
N/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.00
Strong BuyN/AN/A
UpHealth, Inc. stock logo
UPH
UpHealth
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Babylon Holdings Limited stock logo
BBLN
Babylon
$1.15B0.01N/AN/A($10.29) per share-0.05
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$4.01M33.17N/AN/A($0.07) per share-51.14
UpHealth, Inc. stock logo
UPH
UpHealth
$153.15M0.00N/A0.18$7.05 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Babylon Holdings Limited stock logo
BBLN
Babylon
-$221.45M-$23.03N/AN/A-35.54%N/A-105.06%N/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
-$39.76MN/A0.00N/AN/AN/AN/A7/21/2025 (Estimated)
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-$15.36MN/A0.00N/AN/AN/AN/AN/A7/29/2025 (Estimated)
UpHealth, Inc. stock logo
UPH
UpHealth
-$223M-$4.50N/AN/AN/A-49.08%12.33%3.66%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Babylon Holdings Limited stock logo
BBLN
Babylon
N/AN/AN/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/AN/AN/AN/AN/A
UpHealth, Inc. stock logo
UPH
UpHealth
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Babylon Holdings Limited stock logo
BBLN
Babylon
N/A
1.07
1.07
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
0.18
0.15
UpHealth, Inc. stock logo
UPH
UpHealth
N/A
0.13
0.13

Institutional Ownership

CompanyInstitutional Ownership
Babylon Holdings Limited stock logo
BBLN
Babylon
37.90%
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
34.00%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.35%
UpHealth, Inc. stock logo
UPH
UpHealth
23.35%

Insider Ownership

CompanyInsider Ownership
Babylon Holdings Limited stock logo
BBLN
Babylon
38.52%
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
51.40%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
UpHealth, Inc. stock logo
UPH
UpHealth
41.27%
CompanyEmployeesShares OutstandingFree FloatOptionable
Babylon Holdings Limited stock logo
BBLN
Babylon
1,89525.61 million15.75 millionNot Optionable
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
4049.86 million24.23 millionOptionable
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
237.15 millionN/ANot Optionable
UpHealth, Inc. stock logo
UPH
UpHealth
61117.78 million10.44 millionOptionable

Recent News About These Companies

Newsmaker: Navigating a long, bumpy road to success
BharatPe and Ashneer Grover Reach Settlement
CEO of bankrupt health company resigns

Media Sentiment Over Time

Babylon stock logo

Babylon NYSE:BBLN

Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company provides Babylon Cloud and clinical services. Babylon Holdings Limited was founded in 2013 and is headquartered in Austin, Texas.

Better Therapeutics stock logo

Better Therapeutics NASDAQ:BTTX

$0.0001 0.00 (0.00%)
As of 10:20 AM Eastern

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

EUDA Health stock logo

EUDA Health NASDAQ:EUDA

$3.58 -0.14 (-3.76%)
Closing price 03:59 PM Eastern
Extended Trading
$3.69 +0.11 (+3.07%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

UpHealth stock logo

UpHealth NYSE:UPH

UpHealth, Inc., together with its subsidiaries, operates as a digital health services company in the Americas, Europe, and Asia. The company operates through three segments Integrated Care Management, Virtual Care Infrastructure, and Services segments. The Integrated Care Management segment offers SyntraNet, an integrated health management platform that enables clinical and community-based care teams to share information, coordinate care, manage utilization, and improve health outcomes for individuals and populations. The Virtual Care Infrastructure segment provides the Martti platform, a digital health infrastructure that enables its partners to implement unique, private-label telehealth strategies customized to their specific needs and markets, including integrated telehealth and language access services. Its platform also offers telemedicine, such as telestroke, teleneurology, and telepsychiatry services. The Services segment offers behavioral health and pharmacy services, as well as operates HelloLyf CX platform for digital dispensary services and HelloLyf HX platform for digital hospital services; and provides diagnostic laboratory testing services. UpHealth, Inc. was founded in 2019 and is headquartered in Delray Beach, Florida.